Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response and those with partial or no response?-Reference-Cited by-同舟云学术

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response and those with partial or no response?

Published:2009-12 Issue:6 Volume:138 Page:1309-1317
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Meguid Robert A.,Hooker Craig M.,Taylor Joshua T.,Kleinberg Laurence R.,Cattaneo Stephen M.,Sussman Marc S.,Yang Stephen C.,Heitmiller Richard F.,Forastiere Arlene A.,Brock Malcolm V.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference16 articles.

1. Multimodality therapy for esophageal cancer;Forastiere;Chest,1997

2. Pharmacotherapy for oesophagogastric cancer;Jackson;Drugs,2007

3. Resection for esophageal cancer: strategies for optimal management;Pennathur;Ann Thorac Surg,2008

4. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer;Reynolds;Ann Surg,2007

5. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The patterns and risk factors for relapse in oesophageal squamous cell cancers that achieve pathological complete response to neoadjuvant chemoradiotherapy;European Journal of Cardio-Thoracic Surgery;2024-05-29

2. Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma;Cancer Medicine;2024-03

3. Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta‐analysis;Cancer Medicine;2024-02

4. A Comparison of Clinicopathologic Outcomes and Patterns of Lymphatic Spread Across Neoadjuvant Chemotherapy, Neoadjuvant Chemoradiotherapy, and Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma;Annals of Surgical Oncology;2023-11-10

5. Patient choice of surgery or surveillance following a clinical complete response to neoadjuvant chemoradiotherapy for oesophageal carcinoma;British Journal of Surgery;2023-11-02